Relief Therapeutics Holding AG (RLFTF)

[elonmarx]

Didn't mean to start an argument or violate TOS. Sorry about that

I'm a physician and we're in a pandemic. I want to save lives and get the world back to where it was pre-pandemic. The patient population for Aviptadil is critically ill patients who are on a ventilator or ECMO-- no one is disputing that and like I said, i LIKE the drug and its results.

The other drug I insinuated is a subcutaneous shot you can get as an outpatient and hopefully stay out of the hospital.

Meaning-- their target patient populations do not overlap. Not only that, their ways of administration do not overlap.

So if you were sick and lungs clogged up with ton of fluid and inflammatory exudate, wouldn't you want both an inhaled drug to go to work through the airways, and a subQ or IV drug to go to work through the blood stream?

The more pathways you can exploit to defeat this virus the more lives will be saved, and the quicker we can go back to living our normal pre-COVID lives.

Good luck to all